You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-YB1 antibody (ab12148)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Publishing research using ab12148? Please let us know so that we can cite the reference in this datasheet

Show applications key

ab12148 has been referenced in 13 publications.

  1. Narayan V et al. A multiprotein binding interface in an intrinsically disordered region of the tumor suppressor protein interferon regulatory factor-1. J Biol Chem 286:14291-303 (2011). PubMed: 21245151
  2. Tsai BP, Wang X, Huang L, Waterman ML. Quantitative Profiling of In Vivo-assembled RNA-Protein Complexes Using a Novel Integrated Proteomic Approach Molecular & Cellular Proteomics 10:M110.007358 (2011). PubMed:
  3. Chauhan D et al. Combination of novel proteasome inhibitor NPI-0052 and lenalidomide trigger in vitro and in vivo synergistic cytotoxicity in multiple myeloma. Blood 115:834-45 (2010). IHC; Mouse. PubMed: 19965674
  4. Maher-Laporte M et al. Molecular composition of staufen2-containing ribonucleoproteins in embryonic rat brain. PLoS One 5:e11350 (2010). ICC/IF; Rat. PubMed: 20596529
  5. Jenkins RH et al. A Conserved Stem Loop Motif in the 5'Untranslated Region Regulates Transforming Growth Factor-ß(1) Translation. PLoS One 5: (2010). PubMed: 20865036
  6. Kalra J et al. Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1. Oncogene 29:6343-56 (2010). WB. PubMed: 20838384
  7. Gao Y et al. Inhibition of Y-box binding protein-1 slows the growth of glioblastoma multiforme and sensitizes to temozolomide independent O6-methylguanine-DNA methyltransferase. Mol Cancer Ther 8:3276-84 (2009). WB; Human. PubMed: 19996271
  8. Dong J et al. RNA-binding specificity of Y-box protein 1. RNA Biol 6:59-64 (2009). WB; Human. PubMed: 19098458
  9. Otsuka Y et al. Identification of a cytoplasmic complex that adds a cap onto 5'-monophosphate RNA. Mol Cell Biol 29:2155-67 (2009). ICC/IF; Human. PubMed: 19223470
  10. Jia R et al. Control of the papillomavirus early-to-late switch by differentially expressed SRp20. J Virol 83:167-80 (2009). WB; Human. PubMed: 18945760
  11. Guay D et al. The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells. Cancer Sci 99:762-9 (2008). WB; Human. PubMed: 18307537
  12. Cobbold LC et al. Identification of internal ribosome entry segment (IRES)-trans-acting factors for the Myc family of IRESs. Mol Cell Biol 28:40-9 (2008). WB. PubMed: 17967896
  13. Kozak SL et al. The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J Biol Chem 281:29105-19 (2006). PubMed: 16887808

Publishing research using ab12148? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"